We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Panel Advises Against Approval for MRI Contrast Agent Combidex
FDA Panel Advises Against Approval for MRI Contrast Agent Combidex
March 7, 2005
An FDA advisory panel agreed March 3 not to recommend approval for Advanced Magnetics’ Combidex, an investigational molecular imaging agent.